Lansoprazole Teva Pharma (Lansoprazole)

Lansoprazole works by irreversibly inhibiting the gastric H+/K+ ATPase pump located on the secretory surface of parietal cells. This blockade stops the final step of acid production, leading to a sustained increase in gastric pH and a reduction in both basal and stimulated acid secretion.

The appropriate dose of Lansoprazole Teva Pharma is determined by the prescribing healthcare professional based on the specific indication, severity of disease, patient age, renal function and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual circumstances and consider alternative therapies when appropriate.

To order Lansoprazole Teva Pharma, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazole and other PPIs like omeprazole share the same mechanism of inhibiting the gastric proton pump, but they differ in pharmacokinetic profiles, onset of action and drug‑interaction potential. Lansoprazole may have a slightly longer half‑life and can be less affected by certain CYP2C19 polymorphisms, offering an alternative when other PPIs are unsuitable.

Lansoprazole Teva Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, light and excessive heat to maintain potency throughout the shelf life.

Lansoprazole Teva Pharma is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, preferably in the morning, unless the prescriber advises a different schedule.

Serious but rare risks of Lansoprazole include Clostridioides difficile‑associated colitis, acute interstitial nephritis, and severe skin reactions such as Stevens‑Johnson syndrome. Long‑term therapy may also be linked to decreased calcium absorption, increasing the risk of osteoporosis‑related fractures.

Patients with known hypersensitivity to lansoprazole or any component of the formulation should avoid the product. Caution is advised for individuals with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of certain kidney disorders unless monitored closely.